LEGAPAS®
Natural health product licensed in Canada
- Licence holder
- Pascoe Canada
- NPN or DIN-HM
- 80002081
- Status
- Active licence
- Licence date
- 8 September 2006
- Revision date
- Not provided
- Form
- Extrait fluide
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
Medicinal composition not provided.
Non-medicinal ingredients
Eau purifiée, Alcool
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | minimum: 0.9 g ; maximum: 1.5 g | 1 Tous les jours |
| Enfants | minimum: 12 years | minimum: 0.9 g ; maximum: 1.5 g | 1 Tous les jours |
Uses authorised in Canada
Tradtionally used as a laxative.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Effets indésirables connus
Additional information-only on the package insert leaflet: Side Effects: Very rarely cramp-like gastrointestinal symptoms; In these cases, the dose will have to be reduced. In the course of treatment, you may observe harmless discoloration of your urine. prolonged use or use of higher doses (abuse) may cause disturbances of the water and electrolyte balance. Diarrhea may lead to potassium loss in particular. Potassium loss in turn may give rise to disorders of heart function and muscle weakness, especially if cardiac glycosides (drugs that strengthen the heart muscle), diuretics (drugs that increase urinary output), and/or cortisone and cortisone like-drugs (adrenal cortical steroids) are being taken concomitantly. Prolonged use may lead to excretion of protein and blood in urine. Patients may also experience discoloration of the intestinal mucosa (pseudomelanosis coli), which usually resolves upon discontinuation of the product. Violations of Dosing Schedule and Overdosage: accidental or intetional overdosage may produce painful bowel cramps and severe diarrhoea resulting in water and electrolyte loss, and possibly intense gastrointestinal symptoms. In case of overdosage, call a doctor immediately. Do not take a double dose next time but continue treatment as described in the dosing instructions if you miss a dose.
- Contre-indications
Do not use if you have abdominal pain, nausea, fever, vomiting, hemorrhoids or if you have chronic gastrointestinal disorder. Do not use if you are thiazide diuretics, corticosteroids, licorice root, or other drugs that may aggravate electrolyte imbalance. Do not use if you are pregnant or breastfeeding. Do not within 2 hours of another medicine. Additional information-only on the package insert leaflet: Drug Interactions: Chronic use or abuse may lead to potassium deficiency and thus increase the effects of certain drugs that strengthen the heart muscle (cardiac glycosides) and interfere with the effects of drugs for heart rhythm disturbance (antiarrhymics). Potassium loss may be increased by the concomtiant use of certain drugs that increase urinary output (diuretics), cortisone and cortisone-like drugs (corticosteroids) or liquorice root.
Source
Official Health Canada record, licence 80002081
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.